The antibody binds specifically to NCF1 when phosphorylated at Ser328, a modification induced by PRKCD (Protein Kinase C Delta) . This phosphorylation activates NCF1, enabling its interaction with the NADPH oxidase complex (composed of CYBA, CYBB, and regulatory subunits like NCF2 and NCF4). The complex generates reactive oxygen species (ROS) critical for immune cell function, such as phagocytic killing of pathogens .
Detects phosphorylated NCF1 in neutrophils and macrophages during oxidative burst activity .
Useful for studying immune cell activation in inflammation models .
Validates phosphorylation-dependent activation of NCF1 in cell lysates .
Requires denaturing conditions to resolve the 45–47 kDa protein .
Role in CGD: Mutations in NCF1 impair phosphorylation at Ser328, leading to ROS production defects .
Inflammatory Pathways: NCF1 interacts with TRAF4 and ADAM15, linking oxidative signaling to immune modulation .
Therapeutic Targets: Inhibitors of PRKCD or NCF1 phosphorylation are under investigation for chronic inflammation .
Specificity: The antibody discriminates between phosphorylated and unphosphorylated NCF1, ensuring accurate detection .
Optimization: Dilutions must be tailored to experimental conditions (e.g., IF: 1:200–1:500; ELISA: 1:20,000–1:40,000) .
Cross-Reactivity: No reported cross-reactivity with other proteins .
NCF1 (Neutrophil Cytosol Factor 1), also known as p47-phox, is a 47 kDa cytosolic component of the NADPH oxidase complex. It functions as an organizer protein (NOXO2) that, together with NCF2 and membrane-bound cytochrome b558, is required for activation of the latent NADPH oxidase, which is necessary for superoxide production . NCF1 is primarily detected in peripheral blood monocytes and neutrophils at the protein level . Mutations in NCF1 are associated with chronic granulomatous disease, an immunodeficiency characterized by severe recurrent bacterial and fungal infections due to impaired phagocyte function .
The protein contains several functional domains including SH3 domains and a PX domain that mediates interaction with phosphatidylinositol 3,4-bisphosphate and other anionic phospholipids . In its unphosphorylated state, NCF1 exists in an autoinhibited conformation where intramolecular interactions prevent lipid binding and interaction with other components .
Phosphorylation at Ser328 is a critical post-translational modification that disrupts the autoinhibited state of NCF1 . This phosphorylation event is primarily mediated by Protein Kinase C delta (PKCδ) and directly induces activation of NCF1 and subsequent NADPH oxidase activity . The modification enables NCF1 to translocate from the cytosol to the membrane, where it can interact with other components of the NADPH oxidase complex to facilitate superoxide production.
Research has shown that the phosphorylation state of Ser328 serves as a direct indicator of NCF1 activation status in various experimental systems, making antibodies specific to this modification valuable tools for studying NADPH oxidase regulation .
Based on product specifications from multiple suppliers, Phospho-NCF1 (S328) Antibody can be utilized in various research applications:
The antibody specifically detects endogenous levels of p47-phox protein only when phosphorylated at S328, making it ideal for studying the activation state of NADPH oxidase in various cell types and experimental conditions .
NCF1 undergoes phosphorylation at multiple sites during activation, with Ser328 and Ser304 being two of the most well-characterized:
Research shows that these phosphorylation events may occur sequentially or in concert depending on the stimulus. For example, in IL-27-induced macrophages stimulated with PMA, 2D gel electrophoresis revealed distinct patterns of phosphorylation at S304 compared to control macrophages, suggesting differential regulation of these phosphorylation sites .
The temporal and functional relationship between these phosphorylation events remains an active area of research, with evidence suggesting that they may serve complementary roles in the full activation of the NADPH oxidase complex .
Detection of phosphorylated NCF1 requires careful consideration of experimental conditions:
Cell stimulation protocols:
Sample preparation considerations:
Validation approaches:
The most reliable results are obtained when multiple detection methods are used in combination with appropriate controls .
Several techniques can be employed to distinguish phosphorylated from non-phosphorylated NCF1:
Two-dimensional gel electrophoresis:
Peptide competition assays:
Mass spectrometry approaches:
LC-MS/MS analysis after phosphopeptide enrichment can identify specific phosphorylation sites
This technique has been used for phosphoproteome analysis in studies using PMA-treated macrophages
High-resolution mass spectrometry (e.g., Orbitrap fusion) coupled with appropriate separation techniques allows precise identification of phosphorylation sites
Phosphatase treatment controls:
Treating sample aliquots with lambda phosphatase should eliminate phospho-specific signal while preserving total NCF1 detection
These complementary approaches provide robust verification of phosphorylation status in complex biological samples .
The sequence of events linking NCF1 phosphorylation to NADPH oxidase activation follows a well-established pattern:
In resting cells, NCF1 exists in an autoinhibited conformation where intramolecular interactions prevent binding to membrane components
Upon cell stimulation (e.g., with PMA), PKCδ phosphorylates NCF1 at Ser328
This phosphorylation disrupts the autoinhibitory conformation, enabling:
At the membrane, phosphorylated NCF1 facilitates the assembly of other cytosolic components (NCF2, p40-phox) with membrane-bound elements (gp91-phox, p22-phox)
The fully assembled complex then enables electron transfer from NADPH to molecular oxygen, generating superoxide
This process is evident in experimental systems where increased phosphorylation at Ser328 correlates directly with enhanced reactive oxygen species production, particularly in neutrophils and macrophages responding to inflammatory stimuli .
Robust experimental design for studying NCF1 phosphorylation in disease contexts should include:
Positive controls:
Negative controls:
Method-specific controls:
Disease-specific considerations:
Age-matched and sex-matched controls for animal or human studies
Consideration of comorbidities that might affect NADPH oxidase regulation
Documentation of treatments that could modulate phosphorylation status
Implementation of these controls ensures reliable interpretation of NCF1 phosphorylation data in complex disease models .
Phosphorylation patterns of NCF1 at Ser328 show distinct profiles across immune cell types:
Neutrophils:
Monocytes/Macrophages:
Other immune cells:
These cell type-specific differences must be considered when designing experiments and interpreting results across different immune cell populations .
Several techniques can be employed to study the temporal dynamics of NCF1 phosphorylation:
Time-course Western blot analysis:
Phospho-flow cytometry:
Live-cell imaging approaches:
Challenging due to limitations of introducing phospho-specific antibodies into live cells
Possible through development of biosensors based on phospho-binding domains
Correlative live-cell and fixed-cell imaging at defined time points
Mass spectrometry-based temporal profiling:
Each approach offers different temporal resolution and should be selected based on the specific research question and available resources .